Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis.

Kwon, Ho Jeong

Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. [electronic resource] - International journal of cancer Jan 2002 - 290-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0020-7136

10.1002/ijc.1602 doi


Animals
Anti-Bacterial Agents--pharmacology
Antibiotics, Antineoplastic--pharmacology
Antineoplastic Agents--pharmacology
Aorta--metabolism
Cattle
Cell Adhesion
Cell Division
Cell Movement
Cells, Cultured
Chick Embryo
Clinical Trials as Topic
Collagen--pharmacology
DNA, Complementary--metabolism
Depsipeptides
Dose-Response Relationship, Drug
Drug Combinations
Endothelium, Vascular--cytology
Enzyme Inhibitors--pharmacology
Female
HeLa Cells
Histone Deacetylase Inhibitors
Histone Deacetylases--metabolism
Humans
Laminin--pharmacology
Ligases--metabolism
Male
Mice
Mice, Inbred C57BL
Neoplasm Invasiveness
Neovascularization, Pathologic
Neurofibromin 2--metabolism
Peptides, Cyclic
Proteoglycans--pharmacology
Reverse Transcriptase Polymerase Chain Reaction
Transcription, Genetic
Tumor Suppressor Proteins
Ubiquitin-Protein Ligases
Von Hippel-Lindau Tumor Suppressor Protein